NCT00637455View on ClinicalTrials.gov

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

January 31, 2005

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

fexofenadine HCl

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00637455 - Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel | Biotech Hunter | Biotech Hunter